ArticleJournal of molecular medicine (Berlin, Germany)2025

Targeting myeloid differentiation protein 2 ameliorates rheumatoid arthritis by inhibiting inflammation and ferroptosis via MAPK and NF-κB signaling pathways.

Lirun Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.